	Anastrozole
Breast cancer
Letrozole
Femara
Tamoxifen
Aromatase inhibitors
	early breast cancer
breast cancer
distant metastases
Secondary end points
letrozole
anastrozole
tamoxifen
postmenopausal women
study
contralateral breast cancer
node-positive tumors
FACE trial
AIs
Eligible patients
initial therapy
follow-up
median follow-up
primary objective
treatment
analysis
events
risk
differences
clinical
lymph node-positive breast cancer
months
adjuvant
positive nodes
neoadjuvant endocrine therapy
randomized
contralateral breast
primary core analysis
distant recurrence
greater clinical benefit
years
therapy
antiestrogen therapy
time
superior
population
tumors
exclusion criteria
positive
recurrence

